Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 20/20 | 1.00 |
| ▸ | JAK2 | O60674 | 3/20 | 1.00 |
| ▸ | FLT3 | P36888 | 2/20 | 1.00 |
| ▸ | JAK1 | P23458 | 2/20 | 1.00 |
| ▸ | BRD2 | P25440 | 2/20 | 1.00 |
| ▸ | JAK3 | P52333 | 2/20 | 1.00 |
| ▸ | BRD3 | Q15059 | 2/20 | 1.00 |
| ▸ | BRDT | Q58F21 | 2/20 | 1.00 |
| ▸ | BUB1B | O60566 | 1/20 | 1.00 |
| ▸ | RET | P07949 | 1/20 | 1.00 |
| ▸ | WEE1 | P30291 | 1/20 | 1.00 |
| ▸ | ALK | Q9UM73 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29432552 | 1.00 | BRD4 (1.00) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL265061 | 1.00 | BRD4 (1.00) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL14536137 | 0.94 | BRD4 (0.89) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL31163086 | 0.92 | BRD4 (0.85) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL271198 | 0.92 | BRD4 (0.85) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL30306487 | 0.91 | BRD4 (1.00) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL17526335 | 0.91 | BRD4 (1.00) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL263665 | 0.91 | BRD4 (0.84) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL17526085 | 0.91 | BRD4 (1.00) | BRD4JAK2FLT3JAK1BRD2 | |
| SCHEMBL270925 | 0.91 | BRD4 (0.83) | BRD4JAK2FLT3JAK1BRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673149-A1 | NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA | Trustlife Global Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024179699-A1 | NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA | BASH BIOTECH INC. (US) | 2024-09-06 | — | — | WO | disclosed |